BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10757319)

  • 21. t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis.
    Haraguchi M; Border WA; Huang Y; Noble NA
    Kidney Int; 2001 Jun; 59(6):2146-55. PubMed ID: 11380816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
    González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
    Li Y; Chen N; Yu HJ; Dong XP; Huang QH
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II-induced modulation of rat mesangial cell phenotype.
    Zhang X; O'Malley Y; Robbins ME
    Radiat Res; 1999 Jun; 151(6):725-35. PubMed ID: 10360793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of protease and extracellular matrix protein expression by transforming growth factor-beta 1 in non-small cell lung cancer cells and normal human bronchial epithelial cells.
    Jakowlew SB; Mariano JM; You L; Mathias A
    Biochim Biophys Acta; 1997 Aug; 1353(2):157-70. PubMed ID: 9294010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation and spatial shift in the localization of the mannose 6-phosphate/insulin-like growth factor II receptor during radiation enteropathy development in the rat.
    Wang J; Richter KK; Sung CC; Hauer-Jensen M
    Radiother Oncol; 1999 Feb; 50(2):205-13. PubMed ID: 10368045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
    Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
    J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of human mesangial cell collagen expression by transforming growth factor-beta1.
    Poncelet AC; Schnaper HW
    Am J Physiol; 1998 Sep; 275(3):F458-66. PubMed ID: 9729521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Notch pathway mediates the angiotensin II-induced synthesis of extracellular matrix components in podocytes.
    Yao M; Wang X; Wang X; Zhang T; Chi Y; Gao F
    Int J Mol Med; 2015 Jul; 36(1):294-300. PubMed ID: 25902289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of reactive oxygen species in transforming growth factor-beta1-induced extracellular matrix accumulation in renal tubular epithelial cells.
    Rhyu DY; Park J; Sharma BR; Ha H
    Transplant Proc; 2012 Apr; 44(3):625-8. PubMed ID: 22483454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interactions of ovarian carcinoma cells and human peritoneal mesothelial cells involved in matrix metalloproteinases expressions of ovarian carcinoma cells].
    Zhang JJ; Wang B
    Zhonghua Fu Chan Ke Za Zhi; 2006 Mar; 41(3):194-7. PubMed ID: 16640888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential response of activated versus non-activated renal fibroblasts to tubular epithelial cells: a model of initiation and progression of fibrosis?
    Lewis MP; Norman JT
    Exp Nephrol; 1998; 6(2):132-43. PubMed ID: 9567219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-induced up-regulation of Mmp2 involves increased mRNA stability, redox modulation, and MAPK activation.
    Zhao W; Goswami PC; Robbins ME
    Radiat Res; 2004 Apr; 161(4):418-29. PubMed ID: 15038770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The medicinal serum of yi-shen ruan-jian san antagonized the effect of aristolochic acid on human proximal tubular epithelial cells in vitro].
    Fang J; Chen YP; Yang YF; Zhang M
    Zhongguo Zhong Yao Za Zhi; 2005 May; 30(9):704-8. PubMed ID: 16075740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.
    Singh R; Song RH; Alavi N; Pegoraro AA; Singh AK; Leehey DJ
    Exp Nephrol; 2001; 9(4):249-57. PubMed ID: 11423724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and localisation of extracellular matrix degrading proteases and their inhibitors during the oestrous cycle and after induced luteolysis in the bovine corpus luteum.
    Kliem H; Welter H; Kraetzl WD; Steffl M; Meyer HH; Schams D; Berisha B
    Reproduction; 2007 Sep; 134(3):535-47. PubMed ID: 17709571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
    Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
    J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
    Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
    Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
    Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.